Real‐world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non‐muscle invasive bladder cancer—Implications for global shortage
Abstract Objective This study aims to determine the oncological effectiveness and adverse‐effect profile of the Moscow strain of intravesical bacille Calmette–Guérin (BCG) for intermediate and high‐risk non‐muscle invasive bladder cancer (NMIBC). Materials and methods We performed a retrospective se...
Saved in:
| Main Authors: | Amandeep Arora, Sugam Godse, Mahendra Pal, Ankit Misra, Ravi Teja Sepuri, Naveen Thimiri Mallikarjun, Ajit Gujela, Sachin Patel, Anuj Sharma, Santosh Menon, Ganesh Bakshi, Gagan Prakash |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | BJUI Compass |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/bco2.70034 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol
by: Roberta Monardo, et al.
Published: (2025-01-01) -
Aortic endograft infection with Mycobacterium bovis following intravesical BCG immunotherapy diagnosed via the Karius Test™- case report and review of literature
by: Prateek Sharma, et al.
Published: (2025-06-01) -
Efficacy of intravesical gemcitabine instillation compared with intravesical Bacillus Calmette-Guérin instillation for non-muscle invasive bladder cancer
by: Dong Ha Kim, et al.
Published: (2024-12-01) -
Psoriasis exacerbation following intravesical BCG immunotherapy for bladder carcinoma: A case report
by: Yusuf Can Edek, et al.
Published: (2025-07-01) -
Pneumonitis secondary to intravesical Bacillus-Calmette-Guérin (BCG) immunotherapy
by: Komeil Alattar, MBBS, PGCert, et al.
Published: (2025-09-01)